Published in N Engl J Med on August 21, 2003
French Registry of Acute Coronary Syndrome (Fast-MI) | NCT00673036
French Cohort of Myocardial Infarction Evaluation (FRENCHIE) | NCT04050956
The impact of mobile handheld technology on hospital physicians' work practices and patient care: a systematic review. J Am Med Inform Assoc (2009) 3.68
Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J (2009) 2.68
Improving care for patients with acute coronary syndromes: initial results from the National Audit of Myocardial Infarction Project (MINAP). Heart (2004) 2.38
Health care insurance, financial concerns in accessing care, and delays to hospital presentation in acute myocardial infarction. JAMA (2010) 2.33
PRODUCTIVITY SPILLOVERS IN HEALTHCARE: EVIDENCE FROM THE TREATMENT OF HEART ATTACKS. J Polit Econ (2007) 1.92
Regionalization of care for acute coronary syndromes: more evidence is needed. JAMA (2005) 1.70
Emergency department thrombolysis improves door to needle times. Emerg Med J (2004) 1.60
Differences in patient survival after acute myocardial infarction by hospital capability of performing percutaneous coronary intervention: implications for regionalization. Arch Intern Med (2010) 1.52
Reducing In-Stent Restenosis: Therapeutic Manipulation of miRNA in Vascular Remodeling and Inflammation. J Am Coll Cardiol (2015) 1.52
The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int (2006) 1.47
Tailoring therapy to best suit ST-segment elevation myocardial infarction: searching for the right fit. CMAJ (2003) 1.39
Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study. BMJ (2005) 1.20
Time-to-reperfusion in patients undergoing interhospital transfer for primary percutaneous coronary intervention in the U.S: an analysis of 2005 and 2006 data from the National Cardiovascular Data Registry. J Am Coll Cardiol (2008) 1.19
Patients' perceptions of informed consent in acute myocardial infarction research: a questionnaire based survey of the consent process in the DANAMI-2 trial. Heart (2004) 1.16
The plasminogen fibrinolytic pathway is required for hematopoietic regeneration. Cell Stem Cell (2007) 1.15
Acute myocardial infarction system of care in the third world. Neth Heart J (2012) 1.13
Expedited transfer for primary percutaneous coronary intervention: a program evaluation. CMAJ (2007) 1.13
National performance on door-in to door-out time among patients transferred for primary percutaneous coronary intervention. Arch Intern Med (2011) 1.08
Thrombolysis versus primary percutaneous coronary intervention for ST elevation myocardial infarctions at Chilliwack General Hospital. Can J Cardiol (2009) 1.04
Primary percutaneous coronary intervention versus thrombolytic treatment: long term follow up according to infarct location. Heart (2005) 1.04
Rapid short-duration hypothermia with cold saline and endovascular cooling before reperfusion reduces microvascular obstruction and myocardial infarct size. BMC Cardiovasc Disord (2008) 1.04
Determining geographic areas and populations with timely access to cardiac catheterization facilities for acute myocardial infarction care in Alberta, Canada. Int J Health Geogr (2007) 1.04
Multihospital system membership and patient treatments, expenditures, and outcomes. Health Serv Res (2004) 1.03
Mechanical chest compressions in the coronary catheterization laboratory to facilitate coronary intervention and survival in patients requiring prolonged resuscitation efforts. Scand J Trauma Resusc Emerg Med (2016) 1.03
Access to primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in Canada: a geographic analysis. Open Med (2010) 0.99
Primary angioplasty should be first line treatment for acute myocardial infarction: AGAINST. BMJ (2004) 0.98
Regionalization of ST-segment elevation acute coronary syndromes care: putting a national policy in proper perspective. J Am Coll Cardiol (2006) 0.98
Efficacy and safety of unfractionated heparin versus enoxaparin: a pooled analysis of ASSENT-3 and -3 PLUS data. CMAJ (2006) 0.97
Transfer times and outcomes in patients with ST-segment-elevation myocardial infarction undergoing interhospital transfer for primary percutaneous coronary intervention: APEX-AMI insights. Circ Cardiovasc Qual Outcomes (2012) 0.97
Primary angioplasty for acute myocardial infarction--is it worth the wait? N Engl J Med (2003) 0.97
Assessing the effectiveness of primary angioplasty compared with thrombolysis and its relationship to time delay: a Bayesian evidence synthesis. Heart (2007) 0.96
Myocardial infarction in the elderly. Aging Dis (2010) 0.96
How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease? Eur Heart J (2010) 0.96
Temporal trends in revascularization and outcomes after acute myocardial infarction among the very elderly. CMAJ (2010) 0.95
The impact of initial treatment delay using primary angioplasty on mortality among patients with acute myocardial infarction: from the Korea acute myocardial infarction registry. J Korean Med Sci (2008) 0.93
Oxidative stress-mediated reperfusion injury: mechanism and therapies. Oxid Med Cell Longev (2014) 0.92
Timing, setting and incidence of cardiovascular complications in patients with acute myocardial infarction submitted to primary percutaneous coronary intervention. Can J Cardiol (2006) 0.92
Timely and optimal treatment of patients with STEMI. Nat Rev Cardiol (2012) 0.89
Evolving considerations in the management of patients with left bundle branch block and suspected myocardial infarction. J Am Coll Cardiol (2012) 0.89
Temporal decline in the prognostic impact of a recurrent acute myocardial infarction 1985 to 2002. Heart (2006) 0.89
A simple MR algorithm for estimation of myocardial salvage following acute ST segment elevation myocardial infarction. Clin Res Cardiol (2009) 0.88
Delay to reperfusion in patients with acute myocardial infarction presenting to acute care hospitals: an international perspective. Eur Heart J (2010) 0.88
Percutaneous coronary intervention in elderly patients: is it beneficial? Tex Heart Inst J (2011) 0.88
Treatment delays in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction at the Quebec Heart and Lung Institute. Can J Cardiol (2007) 0.88
Are patients with non-ST elevation myocardial infarction undertreated? BMC Cardiovasc Disord (2007) 0.87
Alcohol and drug use disorders among patients with myocardial infarction: associations with disparities in care and mortality. PLoS One (2013) 0.87
Primary angioplasty for any patient with ST-elevation myocardial infarction? Guideline-adherent feasibility and impact on mortality in a rural infarction network. Clin Res Cardiol (2010) 0.86
Safety and feasibility of prehospital thrombolysis in combination with active rescue PCI strategy for acute ST-elevation myocardial infarction. Neth Heart J (2005) 0.84
A prospective, observational, multicentre study comparing tenecteplase facilitated PCI versus primary PCI in Indian patients with STEMI (STEPP-AMI). Open Heart (2014) 0.84
Guidelines for STEMI. CMAJ (2005) 0.83
Does interhospital transfer improve outcome of acute myocardial infarction? A propensity score analysis from the Cardiovascular Cooperative Project. BMC Cardiovasc Disord (2008) 0.82
Routine diversion of patients with STEMI to high-volume PCI centres: modelling the financial impact on referral hospitals. Open Heart (2015) 0.82
Quality of care for acute myocardial infarction in 58 U.S. emergency departments. Acad Emerg Med (2010) 0.82
Recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction. Heart (2004) 0.82
Recent advances in primary percutaneous intervention for acute myocardial infarction. Heart (2005) 0.82
Myocardial infarction centres: the way forward. Heart (2005) 0.82
Urgent air-medical transport: Right patient, place and time. CMAJ (2009) 0.82
Apyrase treatment of myocardial infarction according to a clinically applicable protocol fails to reduce myocardial injury in a porcine model. BMC Cardiovasc Disord (2010) 0.82
A community-wide perspective into changing trends in the utilization of diagnostic and interventional procedures in patients hospitalized with acute myocardial infarction. Am Heart J (2007) 0.82
Trends in reperfusion therapy of ST segment elevation myocardial infarction in Switzerland: six year results from a nationwide registry. Heart (2005) 0.81
Reperfusion delay in patients treated with primary percutaneous coronary intervention: insight from a real world Danish ST-segment elevation myocardial infarction population in the era of telemedicine. Eur Heart J Acute Cardiovasc Care (2012) 0.81
Coronary angioplasty versus fibrinolytic therapy in acute myocardial infarction. N Engl J Med (2003) 0.80
Should all patients with an acute myocardial infarction be referred for direct PTCA? Heart (2004) 0.80
Systematic Review and Pooled Analyses of Recent Neurointerventional Randomized Controlled Trials: Setting a New Standard of Care for Acute Ischemic Stroke Treatment after 20 Years. Interv Neurol (2016) 0.80
Timely reperfusion for ST-segment elevation myocardial infarction: Effect of direct transfer to primary angioplasty on time delays and clinical outcomes. World J Cardiol (2014) 0.80
Use of secondary prevention pharmacotherapy after first myocardial infarction in patients with diabetes mellitus. BMC Cardiovasc Disord (2014) 0.79
Immediate versus delayed angioplasty in infarct-related arteries with TIMI III flow and ST segment recovery: a matched comparison in acute myocardial infarction patients. Clin Res Cardiol (2009) 0.79
Underuse of an invasive strategy for patients with diabetes with acute coronary syndrome: a nationwide study. Open Heart (2015) 0.79
Stent for Life Initiative: where are we standing and where are we going? Eur Heart J Acute Cardiovasc Care (2012) 0.79
Trends in the Use of Evidence-based Therapies Early in the Course of Acute Myocardial Infarction and its Influence on Short Term Patient Outcomes. Open Cardiovasc Med J (2011) 0.79
Bioconjugation of recombinant tissue plasminogen activator to magnetic nanocarriers for targeted thrombolysis. Int J Nanomedicine (2012) 0.79
Primary Angioplasty for the Treatment of Acute ST-Segment Elevated Myocardial Infarction: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2004) 0.79
As time goes by?: the fallacy of thrombolysis in STEMI networks. Clin Res Cardiol (2011) 0.78
Duration of clopidogrel treatment and risk of mortality and recurrent myocardial infarction among 11 680 patients with myocardial infarction treated with percutaneous coronary intervention: a cohort study. BMC Cardiovasc Disord (2010) 0.78
Primary Angioplasty and Thrombolysis for the Treatment of Acute ST-Segment Elevated Myocardial Infarction: An Evidence Update. Ont Health Technol Assess Ser (2010) 0.78
Has thrombolysis lost its mojo? Heart (2007) 0.78
The appropriateness of single page of activation of the cardiac catheterization laboratory by emergency physician for patients with suspected ST-segment elevation myocardial infarction: a cohort study. Scand J Trauma Resusc Emerg Med (2011) 0.78
Antistreptokinase antibodies: implications for thrombolysis in a region with endemic streptococcal infection. J Clin Pathol (2005) 0.78
Reperfusion therapy of acute ischaemic stroke and acute myocardial infarction: similarities and differences. Eur Heart J (2013) 0.78
Should patients with acute ST elevation MI be transferred for primary PCI? Heart (2004) 0.78
Impact of renal insufficiency on mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. BMC Cardiovasc Disord (2014) 0.77
Earlier reperfusion in patients with ST-elevation myocardial infarction by use of helicopter. Scand J Trauma Resusc Emerg Med (2012) 0.77
Artificial trans fat in popular foods in 2012 and in 2014: a market basket investigation in six European countries. BMJ Open (2016) 0.77
Reperfusion times for ST elevation myocardial infarction: a prospective audit. Mcgill J Med (2007) 0.77
Direct admission versus transfer of AMI patients for primary PCI. Clin Res Cardiol (2010) 0.77
Local Intracoronary Eptifibatide versus Mechanical Aspiration in Patients with Acute ST-Elevation Myocardial Infarction. Int J Vasc Med (2014) 0.77
Delivery of primary percutaneous coronary intervention for the management of acute ST segment elevation myocardial infarction: summary of the Cardiac Care Network of Ontario Consensus Report. Can J Cardiol (2006) 0.77
Early discharge after primary percutaneous coronary intervention for ST-elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care (2013) 0.77
Facilitated percutaneous coronary intervention. Heart (2005) 0.77
Should primary angioplasty be available for all patients with an ST elevation myocardial infarction? Heart (2005) 0.77
One year results of the Middlesbrough early revascularisation to limit infarction (MERLIN) trial. Heart (2005) 0.77
It's a matter of time: contemporary pre-hospital management of acute ST elevation myocardial infarction. Heart (2005) 0.77
Coronary care medicine: it's not your father's CCU anymore. Trans Am Clin Climatol Assoc (2004) 0.76
Providing optimal regional care for ST-segment elevation myocardial infarction: a prospective cohort study of patients in the Hamilton Niagara Haldimand Brant Local Health Integration Network. CMAJ Open (2015) 0.76
Coronary angioplasty versus fibrinolytic therapy in acute myocardial infarction. N Engl J Med (2003) 0.76
Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease--a cost-effectiveness analysis. BMC Cardiovasc Disord (2012) 0.76
Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med (2008) 7.95
Rosuvastatin in older patients with systolic heart failure. N Engl J Med (2007) 7.55
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med (2012) 7.55
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet (2007) 6.77
Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med (2011) 4.81
Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. JAMA (2008) 4.41
Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med (2007) 3.84
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet (2009) 3.55
A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet (2008) 3.12
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. J Am Coll Cardiol (2011) 2.85
In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registry. EuroIntervention (2011) 2.63
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation (2010) 2.54
System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. JAMA (2010) 2.53
Primary angioplasty versus fibrinolysis in acute myocardial infarction: long-term follow-up in the Danish acute myocardial infarction 2 trial. Circulation (2010) 2.47
Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial. JAMA (2008) 2.39
Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial. Lancet (2010) 2.38
Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J (2011) 2.36
Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction. Eur Heart J (2011) 2.32
Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial. JACC Cardiovasc Interv (2013) 2.32
Potential impact of myocardial perfusion scintigraphy as gatekeeper for invasive examination and treatment in patients with stable angina pectoris: observational study without post-test referral bias. Eur Heart J (2005) 2.31
PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses. J Am Coll Cardiol (2010) 2.30
No major differences in 30-day outcomes in high-risk patients randomized to off-pump versus on-pump coronary bypass surgery: the best bypass surgery trial. Circulation (2010) 2.21
Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions. J Am Coll Cardiol (2007) 2.11
Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials. Arch Intern Med (2012) 2.09
Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study. Circulation (2006) 2.09
Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis. BMJ (2008) 2.09
Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes. J Am Coll Cardiol (2007) 2.08
Simple or complex stenting for bifurcation coronary lesions: a patient-level pooled-analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study. Circ Cardiovasc Interv (2011) 2.08
Efficacy of post-operative clopidogrel treatment in patients revascularized with coronary artery bypass grafting after myocardial infarction. J Am Coll Cardiol (2011) 2.04
[Is Danish percutaneous coronary intervention too centralized?]. Ugeskr Laeger (2012) 1.92
Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial. J Am Coll Cardiol (2005) 1.92
Randomized study to assess the effect of thrombus aspiration on flow area in patients with ST-elevation myocardial infarction: an optical frequency domain imaging study--TROFI trial. Eur Heart J (2013) 1.87
Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque? Atherosclerosis (2011) 1.84
Is there any time left for primary percutaneous coronary intervention according to the 2007 updated American College of Cardiology/American Heart Association ST-segment elevation myocardial infarction guidelines and the D2B alliance? J Am Coll Cardiol (2008) 1.82
Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials. Catheter Cardiovasc Interv (2007) 1.77
Predictive value of stroke and transient ischemic attack discharge diagnoses in The Danish National Registry of Patients. J Clin Epidemiol (2002) 1.74
Polymorphism in APOB associated with increased low-density lipoprotein levels in both genders in the general population. J Clin Endocrinol Metab (2005) 1.71
Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. N Engl J Med (2010) 1.70
Hospital variation in mortality after first acute myocardial infarction in Denmark from 1995 to 2002: lower short-term and 1-year mortality in high-volume and specialized hospitals. Med Care (2005) 1.69
Pregnancy associated plasma protein A, a novel, quick, and sensitive marker in ST-elevation myocardial infarction. Am J Cardiol (2008) 1.65
2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry). J Am Coll Cardiol (2009) 1.65
Hereditary hemochromatosis and risk of ischemic heart disease: a prospective study and a case-control study. Circulation (2005) 1.64
Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction. Eur J Heart Fail (2005) 1.64
Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent. Catheter Cardiovasc Interv (2011) 1.62
Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus- and sirolimus-eluting stents (from the SORT OUT IV trial). Am J Cardiol (2012) 1.59
Culprit only or multivessel percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction and multivessel disease. EuroIntervention (2012) 1.55
Outcomes after primary percutaneous coronary intervention in octogenarians and nonagenarians with ST-segment elevation myocardial infarction: from the Western Denmark heart registry. Catheter Cardiovasc Interv (2013) 1.54
Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up. JACC Cardiovasc Interv (2011) 1.53
Evaluation of iterative reconstruction (OSEM) versus filtered back-projection for the assessment of myocardial glucose uptake and myocardial perfusion using dynamic PET. Eur J Nucl Med Mol Imaging (2006) 1.53
Efficacy of everolimus eluting stent implantation in patients with calcified coronary culprit lesions: two-year angiographic and three-year clinical results from the SPIRIT II study. Catheter Cardiovasc Interv (2010) 1.51
TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions. Eur Heart J (2007) 1.50
Left ventricular filling pressure estimation at rest and during exercise in patients with severe aortic valve stenosis: comparison of echocardiographic and invasive measurements. J Am Soc Echocardiogr (2009) 1.50
Routine thrombectomy in percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction: a randomized, controlled trial. Circulation (2006) 1.49
Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction. Circ Cardiovasc Interv (2008) 1.49
Use of myocardial perfusion imaging to predict the effectiveness of coronary revascularisation in patients with stable angina pectoris. Eur J Nucl Med Mol Imaging (2005) 1.48
Moderate overweight is beneficial and severe obesity detrimental for patients with documented atherosclerotic heart disease. Heart (2013) 1.47
Diagnostic accuracy of myocardial perfusion imaging in a study population without post-test referral bias. J Nucl Cardiol (2005) 1.47
A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial. EuroIntervention (2006) 1.46
The prognostic value of pre-discharge exercise testing after myocardial infarction treated with either primary PCI or fibrinolysis: a DANAMI-2 sub-study. Eur Heart J (2004) 1.46
Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial. J Am Coll Cardiol (2004) 1.45
Side branch fractional flow reserve measurements after main vessel stenting: a Nordic-Baltic Bifurcation Study III substudy. EuroIntervention (2012) 1.43
Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial. EuroIntervention (2011) 1.43
Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial. Catheter Cardiovasc Interv (2010) 1.43
A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial. EuroIntervention (2005) 1.42
Frequent change of procedure during coronary artery bypass surgery suggests insufficient preoperative diagnostic strategy. Interact Cardiovasc Thorac Surg (2007) 1.42